Left bundle branch pacing offers a physiologic alternative to biventricular pacing for cardiac resynchronization therapy, requiring a personalized approach based on the underlying conduction substrate.
Does left bundle branch pacing improve resynchronization and clinical outcomes compared to conventional biventricular pacing in patients with heart failure requiring cardiac resynchronization therapy?
This review provides a comprehensive framework for personalizing cardiac resynchronization therapy by integrating left bundle branch pacing based on the patient's specific underlying conduction system substrate.
Biventricular pacing remains the cornerstone of cardiac resynchronization therapy (CRT) in patients with heart failure, with well-established benefits. Left bundle branch pacing (LBBP) offers a physiologic alternative by engaging the native conduction system to restore synchrony and has generated significant enthusiasm. However, the growing adoption of LBBP should be tempered by recognition that a one-size-fits-all approach may not address the underlying substrate, particularly in those with intraventricular conduction delay. While a less-than-optimal LBBP implant may be sufficient in bradycardia patients, its adequacy in heart failure patients, who may require more precise consideration of conduction disease, remains uncertain. This review gives a comprehensive framework for integrating LBBP into CRT, including pre-implant, intraprocedural, and post-implant assessment. It also provides practical guidance on when to pursue LBBP alone, when to supplement with a coronary sinus lead, and when to consider conventional biventricular pacing, with an emphasis on a personalized approach to the underlying conduction substrate for maximal therapeutic benefit.
Joza et al. (Tue,) conducted a review in Heart failure requiring cardiac resynchronization therapy. Left bundle branch pacing (LBBP) vs. Biventricular pacing (BiVP) was evaluated. Left bundle branch pacing offers a physiologic alternative to biventricular pacing for cardiac resynchronization therapy, requiring a personalized approach based on the underlying conduction substrate.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: